FundFollowerFundFollower
Super FundsTop AssetsActivityPortfoliosArticlesAbout

Get the FundFollower newsletter

13F-season insights and notable moves. No spam — unsubscribe anytime.

© 2025 FundFollower. All rights reserved.

Data sourced from public SEC filings.

HomeContact UsSuper FundsTop AssetsAbout

Protagonist Therapeutics Inc.

PTGX

3 institutional investors and hedge funds own PTGX, holding 6,531,257 shares worth $688.8M (latest 13F filings).

Advanced Chart

Who owns Protagonist Therapeutics Inc. stock?

Institutional holders of PTGX — largest position first.

Super Fund
Position
Shares
Curr. Value
Port. %
Activity
Farallon Capital ManagementEquity
6,348,906
$669,174,692
3.83%
+3.33%
Duquesne Family OfficeEquity
159,700
$16,832,000
0.50%
0%
Polen Capital ManagementEquity
22,651
$2,776,560
0.02%
-6.93%

Ownership Statistics

Total Shares Held: 6,531,257
Total Value Reported: $688,783,252
Average Allocation per Portfolio 1.45%
Largest Single Portfolio Allocation: 3.83%
Largest Shareholder: Farallon Capital Management
Change in Total Shares Held (Q on Q): +203,214
Percentage Change in Shares Held (Q on Q): 3.21%
Number of Super Fund Holders: 3
Number of New Holders (Q on Q): 0
Number of Funds with Additions (Q on Q): 1
Number of Funds with Reductions (Q on Q): 1
Number of Funds Fully Divested (Q on Q): 0
Number of Funds with No Change (Q on Q): 1

Ownership Distribution

Loading chart…

Ownership History

Loading chart…

Company Profile

Fundamental Data